A method for evaluating the regulation of gut health in ducks by Moringa stems and leaves based on combined microbiome-metabolome analysis and its application
By combining microbiome and metabolome analysis, the effects of Moringa stems and leaves on the gut health of ducks were systematically analyzed, which solved the problem of lack of combined analysis and precise analysis in existing technologies, and realized the molecular mechanism of gut health and the improvement of gut barrier function in ducks.
Patent Information
- Application Number
- CN202611320037.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-08-28
- Publication Date
- 2026-11-17
AI Technical Summary
Existing technologies lack joint analysis of the microbiome and metabolome, fail to systematically analyze the effects of Moringa on the gut health of ducks, lack precise analysis of the cecal microbiota of ducks, do not involve specific metabolic pathways and functional gene regulation, and have not constructed a complete evidence chain of 'microbiota-metabolites-pathways-phenotype'.
Using a combined analysis strategy of microbiome (16S rRNA gene amplicon sequencing) and metabolomics (UHPLC-MS/MS non-targeted metabolomics), and combined with PICRUSt2 functional prediction, we systematically analyzed the effects of Moringa stems and leaves on the cecal microbiota structure and intestinal metabolic profile of ducks, and constructed a regulatory network of 'microbiota-metabolites-pathways-phenotype'.
This study achieved a systematic integration of the microbiome and metabolome, systematically identified key microbial biomarkers and metabolic pathways regulated by Moringa stems and leaves, revealed the molecular mechanism of Moringa stems and leaves on the gut health of ducks, and constructed an evaluation system for intestinal barrier integrity, which has broad application and promotion value.
Smart Images

Figure CN123108170A_ABST
Abstract
Description
Technical Field
[0001] This invention relates to the fields of animal husbandry and biotechnology, and more specifically to a method and its application for evaluating the regulation of intestinal health in ducks by Moringa stems and leaves based on combined microbiome-metabolome analysis. Background Technology
[0002] The gut microbiota, often referred to as the "second genome" of animals, plays a crucial role in host nutrient metabolism, immune regulation, and the maintenance of intestinal barrier function. In recent years, with the rapid development of high-throughput sequencing and metabolomics technologies, researchers have been able to systematically elucidate the mechanisms by which feed additives affect animal gut health at both the microbiota structure and metabolite levels, providing strong technical support for precision nutritional intervention.
[0003] Moringa ( Moringa oleifera Moringa is a tropical perennial tree whose roots, bark, leaves, seeds, and other parts contain abundant bioactive substances such as flavonoids, polysaccharides, alkaloids, and phenols. Studies have shown that Moringa has antibacterial, anti-inflammatory, and gut-development-promoting effects, and has potential value in maintaining animal health and preventing disease. In livestock and poultry farming, Moringa leaf powder has been proven to improve growth performance and meat quality as a feed additive.
[0004] In the study of the effects of Moringa on animal gut health using multi-omics technologies, some scholars have made preliminary findings on the regulatory effects of Moringa on chicken gut microbiota through metagenomics methods. For example, patent CN105815626A discloses the use of Moringa powder in regulating animal gut microbiota, indicating that Moringa powder can increase the number of beneficial bacteria such as Lactobacillus, Butyrica, and Rosbyrateella in the animal gut. Patent CN116548548A discloses a Moringa extract and its application in products for improving poultry gut health.
[0005] However, existing technologies have the following main shortcomings:
[0006] First, there is a lack of combined microbiome and metabolome analysis. Existing technologies, such as CN 105815626 A, only analyze the effects of Moringa on gut microbiota structure using single-mic techniques such as 16S rRNA sequencing, without systematically linking microbiome changes with host metabolome changes. Single-mic techniques cannot answer the core question of "which functional metabolites are altered due to changes in the microbiota," making it difficult to reveal the mechanism by which Moringa regulates gut health.
[0007] Second, there is a lack of precise analysis of the cecal microbiota of meat ducks. Existing research mainly focuses on models such as chickens and mice, while the gut microbiota structure and metabolic characteristics of meat ducks (especially Muscovy ducks) differ significantly from those of other poultry. As waterfowl, meat ducks have unique gut physiology and microbial ecology, and current technologies lack systematic research on the cecal microbiota community of meat ducks.
[0008] Third, it does not involve specific metabolic pathways and functional gene regulation. Current technologies only describe the bacterial community at the taxonomic level (such as an increase in the abundance of a certain genus), without further revealing the specific metabolic pathways affected by changes in the bacterial community through functional prediction analysis, nor identifying specific differential metabolites and their biological functions through non-targeted metabolomics.
[0009] Fourth, there is a lack of a complete chain of evidence for "microbiota-metabolites-pathways-phenotype". Current technologies have failed to systematically link changes in gut microbiota structure and gut metabolite profiles with phenotypic indicators such as host intestinal barrier morphology and growth performance, and cannot construct a complete mechanism model from "feed addition" to "microbiota regulation" to "metabolic remodeling" and then to "phenotypic improvement".
[0010] Therefore, developing a method that can systematically integrate microbiome and metabolomics data and accurately analyze the regulatory mechanism of Moringa stems and leaves on the intestinal health of ducks is a technical problem that urgently needs to be solved by those skilled in the art. Summary of the Invention
[0011] To address the technological gaps in existing technologies, such as the lack of joint microbiome and metabolome analysis, the lack of duck-specific data, the lack of identification of specific metabolic pathways and differential metabolites, and the lack of a complete evidence chain of "microbiota-metabolites-pathways-phenotype", this invention provides a method for evaluating the regulation of intestinal health in ducks by Moringa stems and leaves based on joint microbiome and metabolome analysis, and its application.
[0012] This invention employs a combined analysis strategy of microbiome (16S rRNA gene amplicon sequencing) and metabolomics (UHPLC-MS / MS non-targeted metabolomics) to systematically analyze the effects of Moringa stems and leaves on the cecal microbiota structure and intestinal metabolic profile of ducks. Furthermore, it uses PICRUSt2 functional prediction to correlate changes in the microbiota with changes in metabolic pathways, constructing a complete regulatory network of "microbiota-metabolites-pathways-phenotype".
[0013] To achieve the above objectives, this application adopts the following technical solution: The primary objective of this application is to provide a method for evaluating the regulation of gut health in ducks by Moringa stems and leaves based on a combined microbiome-metabolome analysis, comprising the following steps: (1) Collect cecal contents samples from ducks fed with Moringa stems and leaves, quick-freeze with liquid nitrogen, and store at -80 ℃; (2) Perform 16S rRNA gene amplicon sequencing on the sample to obtain the bacterial community structure data of ASV and species composition; (3) Perform ultra-high performance liquid chromatography-high resolution mass spectrometry non-targeted metabolomics detection on the sample to obtain metabolomics data; (4) The PICRUSt2 tool was used to predict the function of KEGG microorganisms based on the feature table of ASVs in the microbial community, and the abundance data of predicted metabolic pathways of microorganisms were obtained. (5) The growth performance and jejunal morphological integrity phenotypic indicators of meat ducks were measured, and the microbial structure data, the metabolite data and the metabolic pathway data were analyzed together to construct a "microbial community-metabolite-pathway-phenotype" regulatory network to evaluate the effects of Moringa stems and leaves on the intestinal health of meat ducks.
[0014] As a preferred technical solution, the 16S rRNA gene amplicon sequencing in step (2) uses 338F / 806R primers to amplify the V3-V4 variable region, the sequencing platform is DNBSEQ-G99, the data analysis uses QIIME2 software and DADA2 plugin, and the species annotation is based on the Silva 138 SSURef NR99 database. The non-targeted metabolomics detection described in step (3) used an ACQUITY UPLC HSS T3 column and a QExactive HF-X high-resolution mass spectrometer. Gradient elution was performed using an acetonitrile-water mobile phase, and mass spectrometry data were acquired using electrospray positive and negative ion mode. Peak extraction, quantitative correction, and metabolite identification were performed using Compound Discoverer 3.3 software. Metabolite identification was completed by comparing the mzVault and mzCloud standard spectral libraries with the ChemSpider, KEGG, and HMDB public databases.
[0015] As a preferred technical solution, the method is also used to evaluate the effects of probiotics, herbal extracts, or fermented feed on gut health; the method is also used to evaluate the gut health of broilers, laying hens, pigs, or ruminants.
[0016] Another object of this application is to provide: the use of Moringa stems and leaves in the preparation of an intestinal flora regulator for regulating the cecal flora structure of broiler ducks, wherein the addition of Moringa stems and leaves increases the proportion of Bacteroidetes (Bacteroidetes) in the cecum of broiler ducks at the phylum level. Bacteroidota Firmicutes ( Firmicutes ) and Actinobacteria ( Actinobacteriota The abundance of ) increased significantly; in the phylum Deferobacterium ( Deferribacterota ) and Desulfobacteria ( Desulfobacterota The abundance of ) was significantly reduced.
[0017] As a preferred technical solution, the addition of Moringa stems and leaves also increases the prevalence of Prevotella species in the cecum of ducks at the family level. Prevotellaceae ), Butyric acid cocci ( Butyricicoccaceae ) and Trichophyceae ( Lachnospiraceae The abundance of ) increased significantly; in the family Muscicapidae ( Synergistaceae ) and Amino Acid Cocci ( Acidaminococcaceae The abundance of ) was significantly reduced.
[0018] As a preferred technical solution, the addition of Moringa stems and leaves also makes the cecum of meat ducks classified at the Prevotaceae family UCG-001 ( Prevotellaceae UCG-001), Butyric cocci ( Butyricicoccus ), Prevotellaceae NK3B31 group, Oscillatoria genus ( Oscillibacter ), unclassified genera within the class Clostridium. Clostridia ), genus Schutveria ( Shuttleworthia ), genus *Plasmodium* Subdoligranulum ) and Odorbacterium spp. ( Odoribacter The abundance of ) increased significantly; The addition of Moringa stems and leaves also increased the level of avian Bifidobacteria (Bifidobacteria) in the cecum of ducks at the species level. Bifidobacterium pullorum The abundance of visceral Barnes ( ) increased significantly; Barnesiella viscericola The abundance was significantly reduced.
[0019] Another object of this application is to provide: the application of Moringa stems and leaves in the preparation of regulators for regulating the metabolic pathways of cecal microorganisms in broiler ducks, wherein the Moringa stems and leaves are used to upregulate the predicted pentose phosphate pathway, starch and sucrose metabolism, pentose and glucuronic acid interconversion, and glycerol ester metabolism pathways of cecal microorganisms in broiler ducks.
[0020] Another object of this application is to provide: the application of Moringa stems and leaves in the preparation of regulators for controlling amino acid metabolism in the cecum of ducks, wherein the Moringa stems and leaves are used to regulate the pathways of lysine degradation, tryptophan metabolism, phenylalanine metabolism, arginine and proline metabolism in the cecum of ducks.
[0021] Another object of this application is to provide: the application of Moringa stems and leaves in the preparation of a morphological structure improver for duck jejunum, wherein the Moringa stems and leaves are used to reduce the crypt depth of duck jejunum and increase the ratio of jejunal villus height to crypt depth.
[0022] As a preferred technical solution, in any of the above applications, the Moringa stems and leaves are added to the basic daily diet of broiler ducks in the form of powder, with an addition amount of 6% to 9%.
[0023] As can be seen from the above technical solution, compared with the prior art, the present invention has the following beneficial effects: (1) Achieve joint analysis of microbiome and metabolome This invention overcomes the limitations of single-mathematics technologies by systematically integrating 16S rRNA amplicon sequencing (analyzing "who is playing a role") with non-targeted metabolomics (analyzing "what functional molecules are produced"), and bridging changes in the microbial community with changes in metabolic pathways through PICRUSt2 functional prediction, forming a complete evidence chain of "microbial community structure → functional pathway → metabolites → host phenotype".
[0024] (2) Key microbial markers regulating Moringa stem and leaf function were systematically identified in meat ducks. This invention systematically identified key microbial groups regulated by Moringa stems and leaves in the cecum of broiler ducks (Muscovy ducks), including Bacteroidetes at the phylum level. Bacteroidota ) and Firmicutes ( Firmicutes Butyric acid cocci (family level) Butyricicoccaceae ) and Trichophyceae ( Lachnospiraceae ), genus *Vibrio* at the level of ( Oscillibacter ) and unclassified groups under the class Clostridium Clostridia Butyric acid-producing bacteria, such as those found in Moringa stems and leaves, can serve as objective evaluation indicators for regulating gut health in ducks.
[0025] (3) Identify the specific metabolic pathways regulated by Moringa stems and leaves This invention, through PICRUSt2 functional prediction, discovered that Moringa stems and leaves can significantly upregulate the KEGG metabolic pathways, including the pentose phosphate pathway, starch and sucrose metabolism, and glycerol ester metabolism, in the cecal microbiota of ducks. Through non-targeted metabolomics, 432 differential metabolites and 20 significantly enriched metabolic pathways (15 of which are amino acid metabolic pathways) were identified, providing direct molecular-level evidence for the mechanism of action of Moringa stems and leaves.
[0026] (4) The stems and leaves of Moringa were found to be rich in plant-derived active ingredients. This invention detected a significant enrichment of plant-derived active ingredients from Moringa stems and leaves in the cecal metabolome of broiler ducks, including echinogenone (a strong antioxidant carotenoid), (+)-nemorosone (an anti-inflammatory polycyclic polyisoprenyl pyrogallol), and alpha-eleostearic acid (a conjugated linolenic acid that regulates lipid metabolism), providing metabolomics evidence for the "direct absorption of active ingredients" from Moringa stems and leaves.
[0027] (5) An evaluation system with intestinal barrier integrity as its core was constructed. This invention uses intestinal morphological indicators such as jejunal villus height, crypt depth, and villus-crypt ratio as core phenotypic evidence, combined with changes in microbial community structure and metabolic profile, to directly verify the effect of Moringa stems and leaves on improving intestinal barrier function, making intestinal health assessment more targeted and convincing.
[0028] (6) It has broad application and promotion value. The combined analytical technique provided by this invention is not only applicable to the evaluation of Moringa stems and leaves, but can also be extended to the study of intestinal health regulation mechanisms of other feed additives (such as extracts of traditional Chinese medicine, probiotics, fermented feed, etc.), providing a standardized technical process and scientific evaluation system for the development of precision nutrition feed formulations. Attached Figure Description
[0029] To more clearly illustrate the technical solutions in the embodiments of the present invention or the prior art, the drawings used in the description of the embodiments or the prior art will be briefly introduced below. Obviously, the drawings described below are only embodiments of the present invention. For those skilled in the art, other drawings can be obtained based on the provided drawings without creative effort.
[0030] Figure 1 The study investigated the effects of Moringa stems and leaves on the diversity of gut microbiota in broiler ducks (n=6). A represents the Shannon index curve; B represents the Rank abundance curve, where con1-6 represents the 6 replicates of the control group, and M3-1-M3-6 represents the 6 replicates of the 3% Moringa stem and leaf MOSL group, with other parameters as above; C represents the Venn diagram analysis; DF represents the α-diversity indices: Shannon index, Chao1 index, and phylogenetic diversity index; and G represents the PCoA analysis.
[0031] Figure 2 The diagram shows the taxonomic composition of the effects of Moringa stems and leaves on the intestinal flora structure of ducks according to the present invention; where A represents the phylum level; B represents the family level; C represents the genus level; and D represents the species level.
[0032] Figure 3 The image shows the LEfSe analysis of the effects of Moringa stems and leaves on the intestinal flora of ducks according to the present invention; where A is a comparison between the control group and the MOSL treatment group; and B is a comparison between the control group and the 9% MOSL treatment group.
[0033] Figure 4 Figure 1 shows the results of the effects of Moringa stems and leaves on the KEGG metabolic pathway of gut microbiota in ducks.
[0034] Figure 5The following graphs are provided: Principal component analysis (PCA) plot (A) showing the effect of Moringa stems and leaves on the cecal metabolome of ducks; Orthogonal partial least squares discriminant analysis (OPLS-DA) score plot (B) in the negative ion mode; Orthogonal partial least squares discriminant analysis (OPLS-DA) score plot (C) in the positive ion mode; OPLS-DA permutation test plot (D) in the negative ion mode; and OPLS-DA permutation test plot (E) in the positive ion mode. R²Y(cum) and Q²(cum) represent the cumulative explanatory power and predictive power of the model, respectively.
[0035] Figure 6 The image shows a volcano diagram illustrating the effects of Moringa stems and leaves on differential metabolites in the cecum of ducks. Figure 7 For example: Cluster heatmap of the effects of Moringa stems and leaves on differential metabolites in the cecum of ducks.
[0036] Figure 8 Here is a KEGG enrichment bubble diagram showing the effect of Moringa stems and leaves on the cecal metabolic pathway of ducks according to the present invention.
[0037] Figure 9 Here is a Level 2 bar chart showing the effects of Moringa stems and leaves on the cecal metabolic pathway of ducks. Detailed Implementation
[0038] The technical solutions of the present invention will be clearly and completely described below with reference to the embodiments of the present invention. Obviously, the described embodiments are only some embodiments of the present invention, and not all embodiments. Based on the embodiments of the present invention, all other embodiments obtained by those of ordinary skill in the art without creative effort are within the scope of protection of the present invention.
[0039] Example 1 A method for evaluating the regulation of gut health in ducks by Moringa stems and leaves based on combined microbiome-metabolome analysis (1) Animal model and sample collection Healthy male Muscovy ducks aged 21 days were randomly divided into a control group (basal diet) and a Moringa oleifera stem and leaf treatment group (basal diet supplemented with Moringa oleifera stem and leaf powder, hereinafter referred to as MOSL). After 70 days of age, 6 ducks from each group were randomly selected for slaughter, and cecal contents were immediately collected. A portion of the contents was transferred to liquid nitrogen for flash freezing and then stored at -80℃ for microbiome and metabolome analysis. Simultaneously, jejunal midsection tissue samples were collected and fixed with 4% paraformaldehyde for intestinal tissue morphology detection.
[0040] (2) Methods for gut microbiome analysis Total genomic DNA of microorganisms was extracted from the cecal digesta of broiler ducks using the G3638 kit. DNA purity and integrity were assessed by agarose gel electrophoresis. Using the purified DNA as a template, the V3-V4 variable regions of the bacterial 16S rRNA gene were amplified using primers 338F / 806R; 338F: 5'-ACTCCTACGGGGAGGCAGCA-3', SEQ ID NO.1; 806R: 5'-GGACTACHVGGGTWTCTAAT-3', SEQ ID NO.2. After purifying the PCR amplification products, a sequencing library was constructed, and paired-end sequencing was performed on the DNBSEQ-G99 platform using the accompanying kit. The raw sequencing reads were quality-controlled using Trimmomatic v0.39 software to remove sequences with a Phred quality value below 20 or containing unknown bases (N). Primer sequences were removed using Cutadapt v4.9 software to obtain clean reads. With the help of the built-in DADA2 plugin in QIIME2 2024.10.1 software, the clean read segments were denoising processed, and the paired-end sequence splicing, error correction and chimera removal were completed in sequence to obtain representative sequences of amplicon sequence variants (ASV) and ASV abundance table.
[0041] ASV species classification annotation was completed using the Silva 138 SSURef NR99 database. The Kruskal-Wallis test combined with Dunn's post-hoc pairwise comparison method was used to analyze inter-group differences in α-diversity indices (Chao1 index, Shannon index, and phylogenetic diversity index). β-diversity based on Bray-Curtis distance was calculated using R v4.3.1 software, and the sample grouping patterns were visualized using principal coordinate analysis (PCoA). Linear discriminant analysis (LDA) effect size (LEfSe) was used to screen for differentially expressed microorganisms: first, the Kruskal-Wallis test was used to screen for species with inter-group abundance differences; then, paired Wilcoxon rank-sum tests were performed, and species with LDA scores >2 were identified as marker microorganisms. The PICRUSt2 v2.5.3 software was used to predict the function of representative ASV sequences, and KEGG (Kyoto Encyclopedia of Genetics and Genomes) functional annotation was completed. High-throughput sequencing was performed by Wuhan Saiweier Biotechnology Co., Ltd.; α-diversity: Shannon index (reflecting species diversity), Chao1 index (reflecting species richness), and Phylogenetic Diversity index (reflecting phylogenetic diversity) were calculated to assess the diversity and richness of the microbial community in each group; β-diversity: Principal coordinate analysis (PCoA) was used to assess the significance of differences in microbial community structure among groups based on Bray-Curtis distance.
[0042] (3) Prediction of gut microbiota function ASV sequences were used to perform KEGG function prediction using PICRUSt2 to obtain metabolic pathway information for each sample. Changes in the following metabolic pathways were of particular interest: Carbohydrate metabolism. Lipid metabolism; Metabolism of other amino acids. Transcription-related pathways; Immune disease-related pathways; Further analysis of lower-level pathways, with a focus on: Pentose phosphate pathway; Starch and sucrose metabolism. Pentose and glucuronate interconversions. Glycerol ester metabolism; RNA polymerase pathway; (4) Non-targeted metabolomics analysis methods Samples were stored on dry ice. 100 μL of intestinal chyme was added to 400 μL of pre-cooled extraction buffer (methanol:acetonitrile = 3:1, v / v, -40 ℃) and mixed thoroughly. The mixture was vortexed vigorously for 5 min, sonicated for 15 min, and incubated at 4 ℃ for 1 h, followed by centrifugation at 9660 × g for 15 min. An equal volume of the supernatant was concentrated under vacuum until completely dry. The dried residue was reconstituted with 50 μL of 50% methanol aqueous solution, vortexed at 4 ℃ and 447 × g for 3 min, and then centrifuged at 10000 × g for 15 min. The clear final supernatant was collected for detection by liquid chromatography-mass spectrometry (LC-MS) and subsequent metabolomics profiling.
[0043] Metabolites were separated using an ultra-high performance liquid chromatography (UHPLC) system. The chromatographic column was a Waters ACQUITY UPLCHSS T3 column (2.1 mm × 150 mm, 1.7 μm particle size; Waters Corporation, USA). Mass spectrometry data were acquired using a Thermo Fisher Q Exactive HF-X high-resolution mass spectrometer in tandem. The mobile phases were: positive ion mode: 0.1% formic acid aqueous solution (phase A) - 0.1% formic acid acetonitrile (phase B); negative ion mode: 5 mM ammonium acetate aqueous solution (phase A) - acetonitrile (phase B). A gradient elution program was used at a flow rate of 0.3 mL / min and a column temperature of 40 °C. Mass spectrometry employed electrospray ionization (ESI) in both positive and negative ion modes. The primary mass spectrometry resolution was set to 120,000, with a mass-to-charge ratio scan range of m / z 70–1050. The secondary mass spectrometry used a data-dependent acquisition mode, with a normalized collision energy gradient. Compound Discoverer 3.3 software was used to extract peaks, align peaks, quantify substances, and correct retention times from the raw instrument data. Metabolite identification was completed by comparing the secondary mass spectrometry (MS / MS) spectra with the mzVault, mzCloud, ChemSpider, KEGG, HMDB databases and the local mzVault standard spectral library.
[0044] Principal component analysis (PCA) and orthogonal partial least squares discriminant analysis (OPLS-DA) were performed using R software, and the reliability of the OPLS-DA model was verified using permutation tests. A dual screening threshold was set to screen differentially expressed metabolites: OPLS-DA model projected variable importance (VIP) > 1, independent samples t-test P < 0.05; metabolites with a fold change (FC) > 1 were considered significantly upregulated, and those with FC < 1 were considered significantly downregulated. KEGG pathway enrichment analysis was performed on differentially expressed metabolites between the control group and the 9% Moringa stem and leaf powder (MOSL) group to analyze the differences in metabolic function between the two groups. All metabolomics detection and bioinformatics analysis were completed by APExBIO Technology LLC.
[0045] (5) Methods for morphological examination of jejunal tissue Fixed jejunal tissue samples were dehydrated, cleared, impregnated with paraffin, and embedded to prepare paraffin sections with a thickness of 5 μm. After hematoxylin-eosin (HE) staining, the intestinal morphology and structure were observed under an optical microscope. Villous height and crypt depth were measured using image analysis software, and the villous-crypt ratio (villous height / crypt depth) was calculated. Ten morphologically intact villi were randomly selected from each sample for measurement, and the average value was used for statistical analysis.
[0046] Example 2 9% MOSL Addition Scheme Animal model: Healthy male Muscovy ducks aged 21 days with an average weight of 491.11 ± 30.41 g were selected and randomly divided into a control group and a Moringa stem and leaf treatment group, with 6 replicates in each group.
[0047] Dietary formulation: The basal diet of the Moringa stem and leaf treatment group was supplemented with 9% Moringa stem and leaf powder (MOSL). The control group was fed the basal diet (as shown in Table 1).
[0048] Sampling protocol: Cecal contents were collected from 70-day-old animals after slaughter, flash-frozen in liquid nitrogen, and stored at -80°C for 16S rRNA sequencing and untargeted metabolomics analysis; jejunal tissue was also collected for morphological detection.
[0049] Example 3 6% MOSL Addition Scheme Difference from Example 2: Moringa stem and leaf powder was added at 6% (Table 1).
[0050] Example 4 The difference from Example 2 is that the amount of Moringa stem and leaf powder added is 3% (Table 1).
[0051] Example 5 The difference from Example 2 is that the amount of Moringa stem and leaf powder added is 12% (Table 1).
[0052] Table 1. Ratios and nutrient content of experimental diets for meat ducks (21–70 days, dry matter basis)
[0053] ¹ The premix provides per kilogram of diet: VA 3000 IU, VD 32000 IU, VE 20 IU, VK 32.0 mg, VB1 2.0 mg, VB2 10.0 mg, VB6 4.0 mg, VB 12 0.02 mg, folic acid 1.0 mg, niacin 50 mg, pantothenic acid 11 mg, biotin 0.15 mg, Cu (CuSO4·5H2O) 8 mg, Fe (FeSO4·7H2O) 60 mg, Mn (MnSO4·H2O) 100 mg, Zn (ZnSO4·H2O) 60 mg, Se (Na2SeO3) 0.30 mg, I (KI) 0.40 mg, choline 1000 mg.
[0054] 2 ME is calculated based on the "Nutritional Requirements of Duck" (GB / T 45103-2024), and the rest are measured values.
[0055] Example 6 Practical application of evaluation methods The method of Moringa stems and leaves regulating the gut health of broiler ducks, based on the combined microbiome-metabolome analysis of Example 1, was used to evaluate the gut health of male Muscovy ducks treated in different groups in Examples 2-5. The specific process is as follows: Step 1: Male Muscovy ducks fed to 70 days of age in different groups in Examples 2-5 were used as experimental subjects.
[0056] Step 2: After slaughter, collect the contents of the cecum. One part is stored at -80℃ for microbiome analysis, and the other part is used for non-targeted metabolomics analysis. At the same time, collect jejunum tissue for morphological index determination.
[0057] Step 3: Analyze the bacterial community structure using 16S rRNA gene V3-V4 region amplicon sequencing. Figures 1-3 Metabolomics profiles were analyzed using UHPLC-MS / MS non-targeted metabolomics. Figures 5-7 ).
[0058] Step 4: Perform KEGG functional prediction on the bacterial community ASV sequences using PICRUSt2. Figure 4 ), pathway enrichment analysis of differentially metabolites was performed using the KEGG database ( Figures 8-9 ).
[0059] Step 5: Systematically correlate changes in gut microbiota, metabolites, and metabolic pathways with host growth performance and jejunal morphological integrity indicators to reveal the complete mechanism by which Moringa stems and leaves regulate the gut health of ducks.
[0060] The specific measurement results are as follows: Regulation of gut microbiota structure (1) α-diversity analysis like Figure 1 As shown in AC, the Shannon exponential curve tends to stabilize. Figure 1 (A) indicates that the sequencing depth is sufficient to cover microbial species information; the rank abundance curve is wide and nearly flat. Figure 1 The Shannon index (B) indicates a rich and even species composition. The 9% MOSL group's Shannon index (B) indicates a rich and even species composition. Figure 1 D), Chao1 index ( Figure 1 (E) and Phylogenetic Diversity Index ( Figure 1 The highest values for F and F indicate that this group of microbial communities is more extensive and diverse, with increased species richness and greater phylogenetic diversity.
[0061] (2) β-diversity analysis like Figure 1As shown in Figure G, this is the principal coordinate analysis (PCoA) plot showing the effect of Moringa stems and leaves on the β diversity of gut microbiota in broiler ducks. The PCoA plot explains 38.89% of the differences in gut microbiota. The control group and the MOSL treatment group showed a separation trend and the difference was significant (P = 0.038), indicating that Moringa stems and leaves had a significant impact on the colonization of cecal microorganisms in broiler ducks.
[0062] (3) Taxonomic composition of the microbial community Phylum level (Figure 2, A): Bacteroidetes phylum of the MOSL group ( Bacteroidota (Participating in polysaccharide degradation and short-chain fatty acid production), Firmicutes ( Firmicutes It contains a large number of butyric acid-producing bacteria and actinomycetes ( Actinobacteriota The abundance of three species (including various beneficial bacteria that participate in vitamin synthesis) was significantly increased; the abundance of iron-depleting bacteria ( Deferribacterota (usually associated with intestinal inflammatory response), Dethiobacteria ( Desulfobacterota (Some taxa can produce hydrogen sulfide, which is associated with intestinal epithelial damage) Both were significantly reduced in abundance.
[0063] Family level (Figure 2, B): MOSL group, Prevotellaceae ( Prevotellaceae Fiber-degrading bacteria, producing short-chain fatty acids), Butyric acid cocci ( Butyricicoccaceae Butyric acid-producing bacteria, maintaining the intestinal barrier), Trichophyceae ( Lachnospiraceae The abundance of butyric acid-producing bacteria (with anti-inflammatory effects) and other bacteria increased; the abundance of symbiotic bacteria ( Synergistaceae ), Amino acid cocci ( Acidaminococcaceae Abundance decreased.
[0064] Genus level (C in Figure 2): MOSL group, Prevotellaceae family, UCG-001 ( Prevotellaceae UCG-001 Fiber degradation, producing short-chain fatty acids), Butyric acid cocci ( Butyricicoccus Butyric acid production, anti-inflammatory, and intestinal barrier maintenance), Prevotellaceae NK3B31 group (fiber degradation), Oscillatoria genus ( Oscillibacte r, produces butyrate, regulates intestinal homeostasis; unclassified genus within the class Clostridium. Clostridia (Produces butyric acid, anti-inflammatory), *Shutovella* spp. ( Shuttleworthia (Participating in carbohydrate metabolism), *Subdoligranulum* (producing butyric acid), *Ostomyces* (… Odoribacter The abundance of short-chain fatty acids and other compounds increased significantly. Cloacibacillus Abundance decreased.
[0065] Seed level (D in Figure 2): MOSL group of avian Bifidobacterium ( Bifidobacterium pullorum Increased abundance of visceral Barnes bacteria ( Barnesiella viscericola Abundance decreased.
[0066] (4) LEfSe differential species analysis like Figure 3 As shown in Figure A, LEfSe analysis (LDA>2.0) revealed that the control group was enriched with microbial groups such as o_ClostridiavadinBB60 group and s_Butyricimonas; while the MOSL-treated group was enriched with microbial groups such as g_Shuttleworthia, g_Subdoligranulum, g_Odoribacter, g_Oscillibacter, and g_Desulfovibrionaceae.
[0067] The control group and the 9% MOSL group were compared pairwise ( Figure 3 (B) The control group was significantly enriched with microbial groups such as o_ClostridiavadinBB60 group, g_Subdoligranulum, and p_Elusimicrobiota; the 9% MOSL group was significantly enriched with dominant bacterial groups such as g_Shuttleworthia, f_Butyricicoccaceae, f_Ruminococcaceae, o_Lachnospirales, o_Oscillospirales, and c_Clostridia.
[0068] The above results indicate that Moringa stems and leaves can optimize the cecal microbiota structure in a dose-dependent manner, promote the proliferation of beneficial bacteria such as butyrate-producing bacteria, and reduce the abundance of intestinal inflammation-related groups, with the 6% and 9% MOSL groups showing the best effects.
[0069] Gut microbiome function prediction To investigate whether changes in the structure and composition of the gut microbiota would lead to functional alterations, this invention uses PICRUSt2 to perform KEGG prediction analysis on ASV sequences.
[0070] like Figure 4 As shown, the main metabolic pathways affected by the gut microbiota of broiler ducks are carbohydrate metabolism, immune disease, lipid metabolism, metabolism of other amino acids, and transcription, and there are significant differences between treatment groups.
[0071] Further analysis of lower-level pathways revealed that, compared with the control group, the following pathways were significantly upregulated in the MOSL group: Pentose phosphate pathway; Starch and sucrose metabolism. Pentose and glucuronate interconversions. Glycerol ester metabolism; RNA polymerase pathway.
[0072] This is closely related to the fact that the MOSL group is enriched with a large number of dominant microbial communities related to fiber fermentation and butyric acid production.
[0073] Gut metabolomics analysis (1) Multivariate statistical analysis PCA score chart ( Figure 5 (A) shows a clear separation trend between the sample points of the control group and the 9% MOSL group, with high intra-group repeatability. OPLS-DA score plot ( Figure 5 The OPLS-DA permutation test plot (BC) shows that the two groups are completely separated along the predicted principal component T score[1], and the groups exhibit clustering characteristics. Figure 5 The DE (deterministic analysis) showed that the Y-intercept of Q² was less than 0 in both positive and negative ion modes, indicating that the model was not overfitted and was reliable.
[0074] (2) Identification of differential metabolites Screening was conducted based on VIP>1.5 and P<0.05, identifying a total of 432 differentially regulated metabolites, mainly including lipids and lipid-like molecules, organic acids and their derivatives, alkaloids and their derivatives, etc. Of these, 272 were significantly upregulated and 160 were significantly downregulated. Figure 6 ).
[0075] Clustering heatmap ( Figure 7 This shows the expression patterns of the VIP Top 50 differentially expressed metabolites: Metabolites enriched in the control group: Substances related to amino acid and peptide metabolism: glycine, L-homoserine, L-cysteine, tyrosylglycine, gamma-glutamylalanine, glycylleucine, glutamylleucine, etc.
[0076] Lipid metabolism-related substances: Bis(glycerophospho)glycerol, S-Prenyl-L-cysteine, etc.
[0077] Pro-inflammatory metabolites: 20-trifluoroleukotriene B4, etc.
[0078] Metabolites enriched in the 9% MOSL group: Plant-derived active ingredients: Echinenone: a carotenoid with strong antioxidant activity; (+)-Nemorosone: a polycyclic isopentenyl yl phloroglucinol with anti-inflammatory properties; alpha-eleostearic acid: a conjugated linolenic acid that regulates lipid metabolism, etc.
[0079] Fatty acids: Rhodotorulic acid: siderophore, involved in microbial competition; Pelargonic acid: medium-chain fatty acid, antibacterial; 3α-Hydroxyglycyrrhetinic acid: triterpenoid, anti-inflammatory.
[0080] Phospholipids: PS (18:0 / 18:1 (9Z)) Phosphatidylserine: maintains cell membrane function.
[0081] Amino acids: L-proline: a conditionally essential amino acid with antioxidant properties.
[0082] Alkaloids: Conessine: a steroidal alkaloid with antibacterial properties.
[0083] Metabolites that were significantly downregulated in the 9% MOSL group: Amino acids / peptides: Glycine: Enhances protein digestion and absorption, reduces free amino acids; L-Homoserine: Increases microbial utilization; L-Cystine: Increases microbial utilization; Tyrosylglycine: Dipeptide, enhances protein digestion; Gamma-Glutamylalanine: Increases microbial utilization.
[0084] Pro-inflammatory metabolites: 20-trifluoroleukotriene B4: a pro-inflammatory mediator; downregulation indicates reduced inflammation.
[0085] Carotenoids: 2-cis,4-trans-xanthoxin: an oxidative stress product.
[0086] The above results indicate that, compared with the control group, the 9% MOSL group showed enhanced protein digestion and absorption (lower amino acid levels), increased microbial utilization (production of more fatty acids), and increased levels of beneficial functional metabolites, which reduced intestinal inflammatory response, maintained intestinal microecological homeostasis, and maintained intestinal health.
[0087] (3) KEGG pathway enrichment analysis KEGG pathway enrichment analysis ( Figure 8 The study showed that a total of 20 metabolic pathways were significantly enriched, of which 15 were related to amino acid metabolism, including: Lysine degradation; Tryptophan metabolism; Phenylalanine metabolism. Arginine and proline metabolism. In addition, nicotinamide metabolism, glycolysis / gluconeogenesis, and ABC transporters were also enriched, indicating that Moringa stems and leaves can regulate amino acid metabolism, energy metabolism, and transport functions in the cecum of ducks through multiple targets.
[0088] KEGG Pathway Level 2 Bar Chart ( Figure 9The results showed that the most significant changes were concentrated in the Metabolism category, with amino acid metabolism involving the most differentially expressed metabolites (39) and mainly downregulated; metabolites related to cofactors and vitamins metabolism and membrane transport also showed a significant downregulated trend.
[0089] Phenotypic analysis (1) Growth performance determination Weigh the animals at 8:00 AM on days 21, 49, and 70, and record the initial and final weights. Strictly record the amount of feed fed and the amount of leftover feed daily, and calculate the following indicators: Average daily weight gain (ADG, g) = (final weight - initial weight) / number of feeding days; Average daily feed intake (ADFI, g) = Total feed intake / Number of feeding days; Feed conversion ratio (F / G) = Average daily feed intake / Average daily weight gain.
[0090] Table 2 Effects of dietary supplementation with Moringa stems and leaves on the growth performance of broiler ducks (21–70 days)
[0091] Different lowercase letters in the same row of numbers indicate significant differences. P <0.05), the same as in the table below.
[0092] The results showed that during the entire period (21-70 days), the ADG of the 6% and 9% Moringa stem and leaf groups was significantly increased (P=0.041), and the F / G ratio was significantly decreased (P=0.024). Among them, the F / G ratio of the 9% Moringa stem and leaf group was the lowest (2.50), which was 6.7% lower than that of the control group (2.68). During the 50-70 day period, the ADG of the 6% Moringa stem and leaf group was the highest (77.06 g), which was significantly higher than that of the control group (66.75 g, P=0.002).
[0093] (2) Observation of intestinal morphology After slaughter at 70 days of age, 3-4 cm jejunal tissue was collected and fixed in 4% paraformaldehyde. Hematoxylin-eosin (HE) staining was used. After dehydration, paraffin embedding, sectioning, HE staining, dehydration, and mounting, the sections were scanned using a panoramic slide scanner. Villus height (VH) and crypt depth (CD) were measured using Case Viewer software. 10-20 consecutive intestinal villi were measured on each section, and the villus height / crypt depth ratio (VH:CD) was calculated.
[0094] Table 3. Effects of Moringa stems and leaves on the morphological structure and integrity of jejunum in broiler ducks (70 days)
[0095] The results showed that although the villus height in the jejunum of ducks in the Moringa stem and leaf group did not reach a significant level, it showed an increasing trend (P=0.057); the crypt depth was significantly decreased (P=0.003), and the villus height to crypt depth ratio (VH:CD) was significantly increased (P<0.001). Among them, the 9% Moringa stem and leaf group had the highest VH:CD (5.42), which was 33.8% higher than the control group (4.05). The increased VH:CD ratio indicates an increased intestinal absorptive surface area and enhanced digestive and absorptive functions.
[0096] Integrated regulatory model of "microbiota-metabolites-pathways-phenotype" Based on the combined microbiome-metabolome analysis results above, this invention constructs a complete mechanism model for the regulation of intestinal health and metabolism in ducks by Moringa stems and leaves. This mechanism model includes the following five levels: Level 1: Feed additive intervention (moringa stem and leaf addition) Moringa stem and leaf powder was added to the basic diet of broiler ducks as the starting point of the entire regulatory pathway.
[0097] Second level: Cecal microbiota remodeling After Moringa stems and leaves entered the cecum of broiler ducks, they significantly altered the community structure of the intestinal flora. At the phylum level, the abundance of Bacteroidetes, Firmicutes, and Actinobacteria significantly increased. These three phyla are dominant beneficial intestinal flora. Bacteroidetes and Firmicutes are the main groups in the gut that degrade polysaccharides and produce short-chain fatty acids, while Actinobacteria participate in the synthesis of various vitamins. At the family level, the abundance of Prevostidae, Butycocci, and Trichophyceae significantly increased. Prevostidae are important fiber-degrading bacteria, while Butycocci and Trichophyceae are butyric acid-producing bacteria that can maintain intestinal barrier function and exert anti-inflammatory effects by producing butyric acid. At the genus level, butyric acid-producing bacteria such as Oscillatoria, Clostridium, and Butycocci were significantly enriched. Regarding opportunistic pathogens, the abundance of Deferobacterium and Dethiobacterium significantly decreased, as did the abundance of Alphatrophicaceae. These bacteria are usually closely related to intestinal inflammation and intestinal epithelial damage. The above results indicate that Moringa stems and leaves can systematically optimize the cecal flora structure of ducks at multiple taxonomic levels from phylum to species, promote the proliferation of beneficial bacteria such as butyrate-producing bacteria, and reduce the abundance of groups related to intestinal inflammation.
[0098] Level 3: Altered Microbial Function (PICRUSt2 Functional Prediction) Changes in gut microbiota structure are inevitably accompanied by changes in gut microbiota function. KEGG functional prediction of amplicon sequence variants using PICRUSt2 revealed that four metabolic pathways in the cecal microbiota of broiler ducks were significantly upregulated after the addition of Moringa stems and leaves: pentose phosphate pathway, starch and sucrose metabolism, pentose and glucuronic acid interconversion, and glycerol ester metabolism. The enhancement of the pentose phosphate pathway indicates improved energy metabolism and nutrient synthesis capacity of gut microbiota; the upregulation of starch and sucrose metabolism reflects increased utilization efficiency of dietary carbohydrates by gut microbiota; and the enhanced glycerol ester metabolism indicates that Moringa stems and leaves play a positive role in regulating lipid metabolism. These changes in microbial function are closely related to the enrichment of fiber-fermenting bacteria and butyric acid-producing bacteria in the second stratum.
[0099] Level 4: Gut metabolic remodeling (non-targeted metabolomics) Alterations in microbial function and metabolic pathways further drove the overall reshaping of the gut metabolome. Untargeted metabolomics identified 432 differentially expressed metabolites, of which 272 were significantly upregulated and 160 were significantly downregulated. In the 9% Moringa stem and leaf powder treatment group, plant-derived bioactive components were significantly enriched, including ursulphone, nemorone, and α-tungallic acid. These substances are directly derived from Moringa stems and leaves, providing metabolomics evidence for the direct role of Moringa stem and leaf bioactive components in the cecum. Simultaneously, the levels of fatty acid metabolites such as erythromycin and nonanoic acid also significantly increased. Erythromycin acts as a siderophore in intermicrobial competition, while nonanoic acid, as a medium-chain fatty acid, possesses antibacterial activity. These changes reflect a positive adjustment in the gut microbiota. On the other hand, the levels of amino acid and peptide metabolites were significantly reduced in the 9% Moringa stem and leaf powder treatment group. This is not an adverse change, but rather indicates enhanced protein digestion and absorption, and more efficient utilization of amino acids by the microorganisms. Most importantly, the content of 20-trifluoroleukotriene B4, a pro-inflammatory mediator, was significantly reduced, confirming from a metabolic perspective that Moringa stems and leaves can effectively reduce intestinal inflammatory responses.
[0100] Fifth level: Phenotype The aforementioned multi-level microbial and metabolic changes ultimately manifest in the overall improvement of the host's gut health, with enhanced intestinal barrier structural integrity being the core marker of this improvement. Gut microbiota optimization and metabolic remodeling jointly promote jejunal villus development, reduce crypt depth, and increase the villus-crypt ratio, significantly increasing the intestinal absorptive surface area and resulting in a more intact mucosal structure. Morphologically, this confirms the beneficial effects of Moringa stems and leaves on gut health, ultimately supporting improved animal growth performance. In summary, this invention, for the first time, constructs a complete five-level mechanism chain from "feed addition" to "microbiota regulation" to "metabolic remodeling" and then to "phenotypic improvement," providing comprehensive scientific evidence from microorganisms to metabolites to host phenotype for Moringa stems and leaves as a feed additive for broiler ducks. It also provides a standardized microbiome-metabolome joint analysis paradigm for the functional evaluation of other feed additives.
[0101] The various embodiments in this specification are described in a progressive manner, with each embodiment focusing on the differences from other embodiments. The same or similar parts between the various embodiments can be referred to each other.
[0102] The above description of the disclosed embodiments enables those skilled in the art to make or use the invention. Various modifications to these embodiments will be readily apparent to those skilled in the art, and the general principles defined herein may be implemented in other embodiments without departing from the spirit or scope of the invention. Therefore, the invention is not to be limited to the embodiments shown herein, but is to be accorded the widest scope consistent with the principles and novel features disclosed herein.
Claims
1. A method for evaluating the regulation of intestinal health in ducks by Moringa stems and leaves based on combined microbiome-metabolome analysis, characterized in that, Includes the following steps: (1) Collect cecal contents samples from ducks fed with Moringa stems and leaves, quick-freeze with liquid nitrogen, and store at -80 ℃; (2) Perform 16S rRNA gene amplicon sequencing on the sample to obtain the bacterial community structure data of ASV and species composition; (3) Perform ultra-high performance liquid chromatography-high resolution mass spectrometry non-targeted metabolomics detection on the sample to obtain metabolomics data; (4) The PICRUSt2 tool was used to predict the function of KEGG microorganisms based on the feature table of ASVs in the microbial community, and the abundance data of predicted metabolic pathways of microorganisms were obtained. (5) The growth performance and jejunal morphological integrity index of meat ducks were measured, and the microbial structure data, the metabolospectral data and the metabolic pathway data were analyzed together to construct a "microbial community-metabolite-pathway-phenotype" regulatory network to evaluate the effect of Moringa stems and leaves on the intestinal health of meat ducks.
2. The method according to claim 1, characterized in that, The 16S rRNA gene amplicon sequencing described in step (2) used 338F / 806R primers to amplify the V3-V4 variable region. The sequencing platform was DNBSEQ-G99. Data analysis was performed using QIIME2 software and the DADA2 plugin. Species annotation was based on the Silva 138 SSURef NR99 database. The non-targeted metabolomics detection described in step (3) used an ACQUITY UPLC HSS T3 column and a Q Exactive HF-X high-resolution mass spectrometer. Gradient elution was performed using an acetonitrile-water mobile phase, and mass spectrometry data were acquired using electrospray positive and negative ion mode. Peak extraction, quantitative correction, and metabolite identification were performed using Compound Discoverer 3.3 software. Metabolite qualitative analysis was completed by comparing the mzVault and mzCloud standard spectral libraries with the ChemSpider, KEGG, and HMDB public databases.
3. The method according to claim 1, characterized in that, The method is also used to evaluate the effects of probiotics, herbal extracts, or fermented feed on gut health; the method is also used to evaluate the gut health of broilers, laying hens, pigs, or ruminants.
4. The application of Moringa stems and leaves in the preparation of intestinal flora regulators for controlling the cecal flora structure of ducks, characterized in that, The addition of Moringa stems and leaves increases the cecum of ducks to the Bacteroidetes phylum (Bacteroidetes). Bacteroidota Firmicutes ( Firmicutes ) and Actinobacteria ( Actinobacteriota The abundance of ) increased significantly; in the phylum Deferobacterium ( Deferribacterota ) and Desulfobacteria ( Desulfobacterota The abundance of ) was significantly reduced.
5. The application according to claim 4, characterized in that, The addition of Moringa stems and leaves also makes the cecum of ducks more susceptible to Prevotella bacteria at the scientific level. Prevotellaceae ), Butyric acid cocci ( Butyricicoccaceae ) and Trichophyceae ( Lachnospiraceae The abundance of ) increased significantly; in the family Muscicapidae ( Synergistaceae ) and Amino Acid Cocci ( Acidaminococcaceae The abundance of ) was significantly reduced.
6. The application according to claim 4, characterized in that, The addition of Moringa stems and leaves also makes the cecum of the ducks classified as Prevotellaceae UCG-001 at the genus level. Prevotellaceae UCG-001), Butyric cocci ( Butyricicoccus ), Prevotellaceae NK3B31 group, Oscillatoria genus ( Oscillibacter ), unclassified genera within the class Clostridium. Clostridia ), genus Schutveria ( Shuttleworthia ), genus *Plasmodium* Subdoligranulum ) and Odorbacterium spp. ( Odoribacter The abundance of ) increased significantly; The addition of Moringa stems and leaves also increased the level of avian Bifidobacteria (Bifidobacteria) in the cecum of ducks at the species level. Bifidobacterium pullorum The abundance of visceral Barnes ( ) increased significantly; Barnesiella viscericola The abundance was significantly reduced.
7. The application of Moringa stems and leaves in the preparation of regulators for controlling the metabolic pathways of cecal microorganisms in ducks, characterized in that, The moringa stems and leaves were used to upregulate the predicted pentose phosphate pathway, starch and sucrose metabolism, pentose and glucuronic acid interconversion, and glycerol ester metabolism pathways in the cecal microbiota of broiler ducks.
8. The application of Moringa stems and leaves in the preparation of regulators for controlling amino acid metabolism in the cecum of ducks, characterized in that, The moringa stems and leaves are used to regulate the pathways of lysine degradation, tryptophan metabolism, phenylalanine metabolism, and arginine and proline metabolism in the cecum of ducks.
9. The application of Moringa stems and leaves in the preparation of a morphological structure improver for duck jejunum, characterized in that, The moringa stems and leaves are used to reduce the depth of the jejunal crypts in ducks and increase the ratio of downy height to crypt depth.
10. The application according to any one of claims 4-9, characterized in that, The moringa stems and leaves are added to the basic diet of broiler ducks in powder form at a rate of 6% to 9%.
Citation Information
Patent Citations
Purpose of Moringaceae powder for regulating animal intestinal flora
CN105815626A
Moringa oleifera extract and application thereof in preparation of products for improving intestinal health of poultry
CN116548548A
